Ema, Lou Yi Joy P.
HRN: 19-84-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/20/2022
05/27/2022
IV
1gm
Q6
PCAP C
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes